Table 2.
Analysis of EpCAM, CK18, and CK19 and CA15.3 in All Studied Groups
| Parameter | Control | Non metastatic | Metastatic | P value |
|---|---|---|---|---|
| CK18 (%) | 11.3+6.5 | 27.1+15.2 | 66.53+19.1 | P< 0.0001 |
| CK19 (%) | 9.2+3.9 | 22.2+14.7 | 56.2+27.6 | P< 0.0001 |
| CA15.3 (mg/dL) | 7.5 +1.3 | 37.2+11.7 | 82.3+15.7 | P< 0.0001 |
Data are expressed as mean+ SD.